Perfused three-dimensional cell/tissue disease models

• US 8,318,479 B2
• Filed: 05/19/2005
• Issued: 11/27/2012
• Est. Priority Date: 05/19/2004
• Status: Active Grant

• Current Assignee: Massachusetts Institute of Technology, University of Pittsburgh of The Commonwealth System of Higher Education
• Original Assignee: Massachusetts Institute of Technology, University of Pittsburgh of The Commonwealth System of Higher Education
• Inventors: Domansky, Karel, Griffith, Linda G., Tannenbaum, Steven R., Wells, Alan, Inman, Samuel Walker
• Primary Examiner(s): BOWERS, NATHAN ANDREW
• Application Number:
  US11/133,092
• Publication Number:
  US 20050260745A1
• Time in Patent Office: 2,749 Days
• Field of Search: 435/284.1, 435/287.3, 435/288.2, 435/288.3, 435/288.5, 435/293.1, 435/305.1, 435/305.2, 435/305.3, 435/307.1, 435/299.1
• US Class Current: 435/305.2
• CPC Class Codes: B01J 2219/00315 Microtiter plates
• CPC Class Codes: B01J 2219/00743 Cells
• CPC Class Codes: B01L 2300/0681 Filter
• CPC Class Codes: B01L 2300/0829 Multi-well plates; Microtitration plates
• CPC Class Codes: B01L 2300/0861 Configuration of multiple channels and/or chambers in a single devices
• CPC Class Codes: B01L 2400/0481 squeezing of channels or chambers
• CPC Class Codes: B01L 2400/0638 membrane valves, flap valves
• CPC Class Codes: B01L 3/50255 Multi-well filtration
• CPC Class Codes: B01L 3/502715 characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces
• CPC Class Codes: B01L 3/50273 characterised by the means or forces applied to move the fluids micropumps F04B19/006, of the membrane type F04B43/043
• CPC Class Codes: B01L 3/502738 characterised by integrated valves microvalves F16K99/0001
• CPC Class Codes: B33Y 80/00 Products made by additive manufacturing
• CPC Class Codes: C12M 23/12 Well or multiwell plates C12M25/04 takes precedence
• CPC Class Codes: C12M 23/40 Manifolds; Distribution pieces fluid transfer means B01L3/563
• CPC Class Codes: C12M 25/14 Scaffolds; Matrices in general C12N5/0068
• CPC Class Codes: C12M 29/10 Perfusion

Abstract

A system has been constructed that recapitulate the features of a capillary bed through normal human tissue. The system facilitates perfusion of three-dimensional (3D) cell monocultures and heterotypic cell co-cultures at the length scale of the capillary bed. A major feature is that the system can be utilized within a “multiwell plate” format amenable to high-throughput assays compatible with the type of robotics commonly used in pharmaceutical development. The system provides a means to conduct assays for toxicology and metabolism and as a model for human diseases such as hepatic diseases, including hepatitis, exposure-related pathologies, and cancer. Cancer applications include primary liver cancer as well as metastases. The system can also be used as a means of testing gene therapy approaches for treating disease and inborn genetic defects.

Claims

1. An apparatus comprising an array of isolated perfusion bioreactor and reservoir pairs for culturing cells or tissues, the apparatus comprising

a fluidic manifold comprising an array of fluidically isolated perfusion bioreactor and reservoir pairs for cell or tissue culture, and

a control manifold comprising common control channels actuated in parallel to simultaneously act on each pair of bioreactors and reservoirs and means for controlling timing, flow rate and volume of cell culture medium to each bioreactor and reservoir pair,

wherein each fluidically isolated perfusion bioreactor and reservoir pair is connected by a fluidic channel allowing re-circulation of cell culture medium,

wherein each perfusion bioreactor and reservoir pair is fluidically isolated from all other perfusion and bioreactor pairs,

wherein each control channel is separated from the fluidic channel by a diaphragm valve which can be deflected into a valve displacement chamber by hydraulic or pneumatic actuation,

wherein the volume of the cell culture medium pumped through the fluidic channel into either the bioreactor or the reservoir is determined by the volume of the valve displacement chamber, and

wherein each perfusion bioreactor comprises a removable three-dimensional cell or tissue support structure through which the cell culture medium is perfused.

2. The apparatus of claim 1 further comprising a pump.

3. The apparatus of claim 2 wherein the pump is an adjustable volume pump.

4. The apparatus of claim 1 wherein the bioreactor and reservoir pairs, scaffolds or channels are formed by a method selected from the group consisting of photolithography, wet etching, deep reactive ion etching, micromachining, electro-discharge machining, reaction injection molding, thermoplastic injection molding, micromolding, punching, solid free form technologies, micromolding, embossing, laser drilling, and electron beam machining.

5. The apparatus of claim 1 wherein the three-dimensional cell/tissue support structure is made out of porous material.

6. The apparatus of claim 1 wherein the cell/tissue support structure is formed by an array of microchannels in a solid film or sheet supported by a microporous filter or membrane.

7. The apparatus of claim 1 wherein all bioreactors/reservoir pairs in the array are covered by a common removable lid.

8. The apparatus of claim 1 comprising a device for manual or robotic pipetting of cell/tissue seeding, agent addition, or sample collection.

9. The apparatus of claim 1 wherein the bioreactor/reservoir pairs are fabricated or microfabricated in the fluidic manifold.

10. The apparatus of claim 1 wherein the control channels are fabricated or microfabricated in the control manifold.

11. The apparatus of claim 1 comprising diaphragm valves created by sandwiching a monolithic elastomeric membrane between the fluidic and control manifolds.

12. The apparatus of claim 1 wherein cell culture medium in multiple bioreactors is pumped by sequential actuation of the valves connected in series.

13. The apparatus of claim 1 further comprising a first set of cells.

14. The apparatus of claim 13 further comprising a second set of cells introduced after the initial bioreactor tissue is established.

15. The apparatus of claim 14 wherein the second set of cells are tumor cells.

16. The apparatus of claim 14 where the second set of cells are stem cells.

17. The apparatus of claim 13 comprising tumor cells that grow in the environment of liver tissue.

18. The apparatus of claim 13 comprising tumor cells that can be studied for tumor cell behaviors.

19. The apparatus of claim 14 wherein molecular events can be visualized during tumor cell growth.

20. The apparatus of claim 1 wherein the first set of cells can be modified prior to or subsequent to introduction into the apparatus.

21. The apparatus of claim 1 comprising primary tumor cells from patients for diagnostic and prognostic testing.

22. The apparatus of claim 21 wherein the tumor cells can be assessed for sensitivity to an agent or gene therapy.

23. The apparatus of claim 17 wherein tumor cell sensitivity to an agent or gene therapy is linked to liver metabolism of set agent or gene therapy.

24. The apparatus of claim 16 wherein the second set of cells introduced are stem or progenitor cells and the stem or progenitor cells are induced to differentiate by the mature tissue.

25. The apparatus of claim 13 comprising mature cells inducible to replicate by manipulation of the flow rates or medium components in the system.